Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Kallikrein-related peptidase 3 (KLK3/PSA) single nucleotide polymorphisms and ovarian cancer survival.

Twin research and human genetics : the official journal of the International Society for Twin Studies - 1 Aug 2011

O'Mara Tracy A, Nagle Christina M, Batra Jyotsna, Kedda Mary-Anne, Clements Judith A, Spurdle Amanda B

Abstract excerpt

There is substantial evidence suggesting a role for hormone-regulated kallikrein-related peptidases (KLKs) in carcinogenesis and tumour metastasis. KLKs are considered to have potential as prognostic biomarkers for hormone dependent cancers, particularly ovarian cancer. The purpose of this study was to evaluate the association between Kallikrein-related peptidase 3 (KLK3) gene single nucleotide polymorphisms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Clear Cell
Share to Adenocarcinoma, Mucinous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystadenocarcinoma, Serous

Share to Endometrial Neoplasms

Share to Kallikreins

Share to Neoplasm Invasiveness

Share to Prostate-Specific Antigen

Share to Survival Rate

Source

Identifiers

PMID: 21787114
DOI: 10.1375/twin.14.4.323

Genes

KLK3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Kallikrein-related peptidase 3 (KLK3/PSA) single nucleotide polymorphisms and ovarian cancer survival.PMID 21787114Read ↗

Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.Semantic proximity Read ↗

Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript.Semantic proximity Read ↗

Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.Semantic proximity Read ↗

A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival.Semantic proximity Read ↗

Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancerSemantic proximity Read ↗

Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignanciesSemantic proximity Read ↗

Association between three genetic variants in kallikrein 3 and prostate cancer riskSemantic proximity Read ↗

Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome.Semantic proximity Read ↗

A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33.Semantic proximity Read ↗

Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?Semantic proximity Read ↗

Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness.Semantic proximity Read ↗

An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.